Treo Flu vs Bu Flu +/-Thio in SCD from 2010-2014 (extended to 2017), part of first Medac Study Study type Retrospective Studies Diseases Group Paediatric Diseases Working Party (PDWP) Type of treatment Principal investigator Cseh Annamaria
Outcome of children developing grade III-IV aGVHD after allogeneic HSCT Study type Retrospective Studies Diseases Acute Myeloid Leukaemia (AML) Group Paediatric Diseases Working Party (PDWP) Type of treatment Allogeneic Allogeneic - Related Allogeneic - Unrelated Allogeneic - Haploidentical Principal investigator Giovanna Lucchini
Pronostic des enfants développant une GvHD aiguë de grade III-IV après une greffe allogénique de cellules souches hématopoïétiques Study type Études rétrospectives Diseases Leucémie Myéloïde Aiguë (LMA) Group Paediatric Diseases Working Party (PDWP) Type of treatment Allogénique Allogénique - Apparentée Allogénique - Non apparentée Allogénique - Haplo-identique Principal investigator Giovanna Lucchini
Evaluation of Outcomes following Allogeneic HCT in Pediatric Patients with High-Risk AML Study type Retrospective Studies Diseases Acute Myeloid Leukaemia (AML) Group Type of treatment Allogeneic Principal investigator Akshay Sharma
HSCT for Congenital Amegakaryocitic thrombopecytopenia (CAMT) Study type Closed Survey/Study Diseases Bone marrow failure Group Paediatric Diseases Working Party (PDWP) Type of treatment Allogeneic Principal investigator Clémence Aldebert
Greffe de cellules souches hématopoïétiques (HSCT) pour la thrombocytopénie amégacaryocytaire congénitale (CAMT) Study type Enquêtes Diseases Aplasie Médullaire Group Paediatric Diseases Working Party (PDWP) Type of treatment Allogénique Principal investigator Clémence Aldebert
CLL - Projects about PI, ibrutinib and venetoclax Study type Retrospective Studies Diseases Chronic Lymphocytic Leukaemia (CLL) Group Chronic Malignancies Working Party (CMWP) Type of treatment Allogeneic Principal investigator Olivier Tournilhac, Michel van Gelder
LLC - Projets sur les inhibiteurs de la voie des PI, l'ibrutinib et le venetoclax Study type Études rétrospectives Diseases Chronic Lymphocytic Leukaemia (CLL) Group Chronic Malignancies Working Party (CMWP) Type of treatment Allogénique Principal investigator Olivier Tournilhac, Michel van Gelder
Central nervous system disorders following hematopoietic stem cell transplantation: a prospective observational study from the Infectious Diseases Working Party (IDWP) and the Transplant Complications Working Party (TCWP) Study type Non-interventional Prospective Studies Diseases Complications: infectious Complications: non-infectious Group Infectious Diseases Working Party (IDWP) Complications Working Party (CWP) Type of treatment Allogeneic Autologous Principal investigator Martin Schmidt-Hieber
A prospective outcome study on patients with profound combined immune deficiency (p-CID) Study type Retrospective Studies Diseases Group Inborn Errors Working Party (IEWP) Type of treatment Principal investigator Stephan Ehl
LATE COMPLICATIONS AFTER AUTOLOGOUS HSCT FOR AUTOIMMUNE DISEASES: a retrospective survey from the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP) of the European Society for Blood and Marrow Transplantation (EBMT) Study type Retrospective Studies Diseases Group Autoimmune Diseases Working Party (ADWP) Complications Working Party (CWP) Paediatric Diseases Working Party (PDWP) Type of treatment Autologous Principal investigator Kirill Kirgizov
Post AHSCT (Autologous Hematopoietic Stem Cell Transplantation) management for patients with systemic sclerosis: a prospective, non-interventional approach across Europe (NISSC-2) Study type Non-interventional Prospective Studies Diseases Group Autoimmune Diseases Working Party (ADWP) Type of treatment Autologous Principal investigator Pr Dominique Farge